IL27360A - 1,alpha,alpha-trimethyl-2-piperidylcarbinol diphenylacetate,process for the preparation thereof and its use as topical anesthetic - Google Patents
1,alpha,alpha-trimethyl-2-piperidylcarbinol diphenylacetate,process for the preparation thereof and its use as topical anestheticInfo
- Publication number
- IL27360A IL27360A IL2736067A IL2736067A IL27360A IL 27360 A IL27360 A IL 27360A IL 2736067 A IL2736067 A IL 2736067A IL 2736067 A IL2736067 A IL 2736067A IL 27360 A IL27360 A IL 27360A
- Authority
- IL
- Israel
- Prior art keywords
- diphenylacetate
- alpha
- acid addition
- piperidylcarbinol
- process according
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 17
- PYHXGXCGESYPCW-UHFFFAOYSA-M 2,2-diphenylacetate Chemical compound C=1C=CC=CC=1C(C(=O)[O-])C1=CC=CC=C1 PYHXGXCGESYPCW-UHFFFAOYSA-M 0.000 title claims description 10
- 230000003444 anaesthetic effect Effects 0.000 title description 5
- 230000000699 topical effect Effects 0.000 title description 4
- 238000002360 preparation method Methods 0.000 title description 3
- 150000001875 compounds Chemical class 0.000 claims description 11
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 8
- 238000005984 hydrogenation reaction Methods 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 3
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- MSYLETHDEIJMAF-UHFFFAOYSA-N 2,2-diphenylacetyl chloride Chemical compound C=1C=CC=CC=1C(C(=O)Cl)C1=CC=CC=C1 MSYLETHDEIJMAF-UHFFFAOYSA-N 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 6
- DQTZOBGQFRIPRU-UHFFFAOYSA-N 2,2-diphenylacetic acid;hydrochloride Chemical compound Cl.C=1C=CC=CC=1C(C(=O)O)C1=CC=CC=C1 DQTZOBGQFRIPRU-UHFFFAOYSA-N 0.000 claims 1
- 230000032050 esterification Effects 0.000 claims 1
- 238000005886 esterification reaction Methods 0.000 claims 1
- 229910052763 palladium Inorganic materials 0.000 claims 1
- 206010002091 Anaesthesia Diseases 0.000 description 8
- 238000001949 anaesthesia Methods 0.000 description 8
- 230000037005 anaesthesia Effects 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 229960004194 lidocaine Drugs 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 230000011514 reflex Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 235000011121 sodium hydroxide Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 241000700199 Cavia porcellus Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010035039 Piloerection Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000002988 lumbosacral plexus Anatomy 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000005371 pilomotor reflex Effects 0.000 description 1
- RJUAEBLXGFKZMS-UHFFFAOYSA-N piperidin-1-ylmethanol Chemical compound OCN1CCCCC1 RJUAEBLXGFKZMS-UHFFFAOYSA-N 0.000 description 1
- PRAYXGYYVXRDDW-UHFFFAOYSA-N piperidin-2-ylmethanol Chemical compound OCC1CCCCN1 PRAYXGYYVXRDDW-UHFFFAOYSA-N 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
- C08J9/04—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent
- C08J9/06—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent by a chemical blowing agent
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/02—Preparation by ring-closure or hydrogenation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2327/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a halogen; Derivatives of such polymers
- C08J2327/02—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a halogen; Derivatives of such polymers not modified by chemical after-treatment
- C08J2327/04—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a halogen; Derivatives of such polymers not modified by chemical after-treatment containing chlorine atoms
- C08J2327/06—Homopolymers or copolymers of vinyl chloride
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT228666 | 1966-02-03 | ||
| IT1408166 | 1966-02-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL27360A true IL27360A (en) | 1971-01-28 |
Family
ID=26325232
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL2736067A IL27360A (en) | 1966-02-03 | 1967-01-30 | 1,alpha,alpha-trimethyl-2-piperidylcarbinol diphenylacetate,process for the preparation thereof and its use as topical anesthetic |
Country Status (11)
| Country | Link |
|---|---|
| BE (1) | BE693587A (is") |
| CH (1) | CH484905A (is") |
| DK (1) | DK118186B (is") |
| ES (1) | ES336375A1 (is") |
| FR (1) | FR6135M (is") |
| GB (1) | GB1110637A (is") |
| IL (1) | IL27360A (is") |
| NL (1) | NL6701022A (is") |
| NO (1) | NO122068B (is") |
| SE (1) | SE321474B (is") |
| YU (1) | YU32140B (is") |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE7607114L (sv) | 1976-06-22 | 1977-12-23 | Bofors Ab | Sett att framstella hydrokloriden av n-metylpiperidin-2-karbonsyra-2,6-xyllidid |
-
1967
- 1967-01-23 NL NL6701022A patent/NL6701022A/xx unknown
- 1967-01-30 GB GB4503/67A patent/GB1110637A/en not_active Expired
- 1967-01-30 IL IL2736067A patent/IL27360A/en unknown
- 1967-01-30 NO NO16661667A patent/NO122068B/no unknown
- 1967-01-31 YU YU18367A patent/YU32140B/xx unknown
- 1967-01-31 DK DK54467A patent/DK118186B/da unknown
- 1967-01-31 FR FR93178A patent/FR6135M/fr not_active Expired
- 1967-02-01 SE SE139967A patent/SE321474B/xx unknown
- 1967-02-02 CH CH151767A patent/CH484905A/de not_active IP Right Cessation
- 1967-02-02 BE BE693587D patent/BE693587A/xx unknown
- 1967-02-02 ES ES336375A patent/ES336375A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| NO122068B (is") | 1971-05-18 |
| GB1110637A (en) | 1968-04-24 |
| NL6701022A (is") | 1967-08-04 |
| ES336375A1 (es) | 1968-04-01 |
| FR6135M (is") | 1968-06-24 |
| SE321474B (is") | 1970-03-09 |
| CH484905A (de) | 1970-01-31 |
| YU18367A (en) | 1973-08-31 |
| DK118186B (da) | 1970-07-20 |
| BE693587A (is") | 1967-08-02 |
| YU32140B (en) | 1974-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO166616B (no) | Forloesningsbord. | |
| DE2525633A1 (de) | Daunomycinanaloga | |
| DE2343657A1 (de) | Neuer ester eines eckige klammer auf (methylamino)methyl eckige klammer zu benzyl-alkohols | |
| DE2261506A1 (de) | Basische derivate von phenyl-1 alkanolen, ihre herstellung und diese enthaltende medikamente | |
| IL27360A (en) | 1,alpha,alpha-trimethyl-2-piperidylcarbinol diphenylacetate,process for the preparation thereof and its use as topical anesthetic | |
| Adams et al. | Stereochemistry of the Pyrrolizidine Bases | |
| CH437252A (de) | Verfahren zur Herstellung von Catechol-O-methyltransferase-Inhibitoren | |
| DE1245357B (de) | Verfahren zur Herstellung von basischen AEthern von substituierten Hydroxybenzoesaeureamiden | |
| DE1620379A1 (de) | Verfahren zur Herstellung neuer Phenylaethanolpiperazinderivate | |
| Marshall et al. | Pharmacologic studies on some compounds structurally related to the hemicholinium HC-3 | |
| DE2541932A1 (de) | Piperidinderivate, verfahren zu ihrer herstellung und sie enthaltendes pharmazeutisches mittel | |
| DE1543769A1 (de) | Verfahren zur Herstellung von Flavanderivaten | |
| Lamberton | Studies of the optically active compunds of anacardiaceae exudates. Vi. The exudate from Pentaspadon officinalis Holmes | |
| US3560511A (en) | Topical anaesthetic piperidyl carbinol | |
| DE951722C (de) | Verfahren zur Herstellung von (-)-3-Oxy-N-propargylmorphinan | |
| AT266133B (de) | Verfahren zur Herstellung des neuen 1,α,α-Trimethyl-2-piperidylcarbinol-diphenylacetats und dessen Salzen mit pharmazeutisch verträglichen Säuren | |
| DE2344681A1 (de) | Substituierte 2-hydroxy-2-phenylaethylamine | |
| DE1695681C (de) | l,alpha,alpha Trimethyl 2 pipendylcarbi nol diphenylacetat, dessen Saureadditions salze und Verfahren zu deren Herstellung | |
| AT213394B (de) | Verfahren zur Herstellung des neuen β-Hydroxybuttersäure-cyclohexylamids | |
| DE2036633A1 (de) | Arzneimittel mit entzündungshemmender, analgetischer und antipyretischer Wirksam | |
| DE2357748C3 (de) | 3,4-Dipivaloxy-alpha- eckige Klammer auf (isopropylamino)-methyl eckige Klammer zu - benzylalkohol, dessen Säureadditionssalze und sie enthaltendes Arzneimittel | |
| DE890800C (de) | Verfahren zum Herstellen von p-Aminosalicylsäure | |
| CH512443A (de) | Verfahren zur Herstellung neuer basisch substituierter Phenylacetonitrile | |
| US2582587A (en) | N-alkylaminopropiophenones | |
| AT282593B (de) | Verfahren zur herstellung von neuem racemischem oder optisch aktivem (1-2'-nitrilophenoxy)-2-hydroxy-3-isopropylaminopropan und dessen salzen |